Our findings also implicate impairment in mitochondrial machinery, cholesterol metabolism, inflammatory responses, regulation of cytoskeletal proteins, receptor mediated endocytosis and retinoid nuclear receptor alterations in glaucoma conditions. The gene discussed is DNM2; the disease is glaucoma.